Close

Dainippon wins manufacturing approval for sleep inducing therapy in Japan

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Green Chemistry in EU Shapes Pharmaceutical Intermediates

Green chemistry is a cutting-edge scientific discipline that focuses...

Reviving Old Drugs with Specialty Intermediates in Europe

Drug development in the European pharmaceutical industry is undergoing...

EU Green Regulations Impact Pharmaceutical Chemical Industry

Pharma specialty chemicals companies have been experiencing serious challenges...

Indian Pharma Grows 8% CAGR, Surpassing Global Average

The Indian pharma sector has seen 8% CAGR growth...

Dainippon Sumitomo Pharma has obtained manufacturing and marketing approval for Zolpidem tartrate tablets 5mg/10mg [DSP] from the Ministry of Health, Labour and Welfare in Japan. Zolpidem tartrate tablets 5mg/10mg [DSP] are film-coated tablets containing 5mg or 10mg of zolpidem tartrate, with a score line on one side, which are indicated for the treatment of Insomnia. The usual adult dose is once daily 5 to 10mg of zolpidem tartrate administered orally immediately before bedtime, the company said. The initial dose for elderly patients is from 5mg once daily and may be adjusted depending on age, symptoms, disease, and should not exceed 10mg once daily.

Latest stories

Related stories

Green Chemistry in EU Shapes Pharmaceutical Intermediates

Green chemistry is a cutting-edge scientific discipline that focuses...

Reviving Old Drugs with Specialty Intermediates in Europe

Drug development in the European pharmaceutical industry is undergoing...

EU Green Regulations Impact Pharmaceutical Chemical Industry

Pharma specialty chemicals companies have been experiencing serious challenges...

Indian Pharma Grows 8% CAGR, Surpassing Global Average

The Indian pharma sector has seen 8% CAGR growth...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back